參考文獻
1. Ross JS et al., “Targeted therapies for cancer”, Am J Clin Pathol ,122, pp.598-609,2004.
2. J. Martin Brown et al.,” The role of apoptosis in cancer development and treatment response”, NATURE REVIEWS, 5,pp231-237,2005.
3. 水野卓，川合正允著，《菇類的化學、生化學》，賴慶亮譯，臺北臺灣，國立編譯館，民國八十六年。
4. Lee, J. W and Chung et al., “Effects of alkali extract of Ganoderma lucidum IY007 on complement and reticuloendothelial system”,Han’guk Kyunhakhoechi, 18,pp. 137-144,1996.
5. Komoda, Y et al., “Ganoderic anid and its dervatives as cholesterol synthesis inhibitors”, Chem. Pharm. Bull., 37(2),pp.531-533 ,1989.
6. Wasser, S. P., and Weis, A. L., “Therapeutic effects of substances occurring in higher Basidiomycetes mushroom: a modern perspective”, Critical Rev. Immunol.,19: 65-96, 1999.
7. Torres K et al,”Mechanisms of Taxol-induced cell death are concentration dependent”,Cancer Res,58,pp.3620-6,1998.
8. Kohn EC et al,”Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer”, J Natl Cancer Inst. ,86,pp.18-24,1994.
9. Melanie S. Flint et al.,” Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway”, Psychoneuroendocrinology, 34(10), pp.1533-1541,2009.
10. Kazutoshi Isobe et al.,” Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer”, Lung Cancer, 66( 3),pp.350-354,2009.
11. Ming-Ho Chen et al.,” The molecular mechanism of gypenosides-induced G1 growth arrest of rat hepatic stellate cells”, Journal of Ethnopharmacology, 117(2), pp.309-317,2008.
12. Jung-Chou Chen et al.,” Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer SCC-4 cells”, Oral Oncology, 45(3),pp. 273-283, 2009.
13. 臧穆、蘇慶華，＜我國台灣產靈芝屬新種樟芝＞，雲南植物研究，第12卷，395-396頁，民國七十九年。
14. Chang, T. T.and W. N. Chou,” Antrodia cinnamomea sp. nov. on Cinnamomum kanehirai in Taiwan”, Mycol. Res, 99, pp. 756-758, 1995.
15. S.H. Wu et al., “Antrodia camphorate (“niu-chang-chin”), new combination of a medicinal fungus in Taiwan”, Botanical Bulletin of Academic Sinica, 29, pp.273-275,1997.
16. S.J. Stasinopoulos and R.J. Seviour, “Exopolysaccharide production by Acremonium persicinum in stirred-tank and air-lift fermentors”, Applied and Microbiology Biotechnology, 36, pp.465-468, 1992.
17. 王伯徹、黃仁彰，＜靈芝與樟芝之研究與市場面面觀＞，食品工 業，第34卷，3-17頁，民國九十一年。18. Wu, S. H et al., ”Taiwanofungus, a polypore new genus”, Fung. Sci., 19, pp.109-16, 2004.
19. 張益軒，＜Molecular Systematics of Antrodia camphorata＞，國立 台灣大學，碩士論文，民國九十一年。
20. 高曉薇，＜台灣靈芝屬新種樟芝之三萜類成份研究＞，台北醫學大學，碩士論文，民國八十年。21. Chang, H.L et al., “Non-volatile taste components of Agaricus blazei, Antrodia camphorata and Cordyceps militaris mycelia”. Food Chemistry, 74,pp. 203-207, 2001
22. Chang, H.L et al., “Non-volatile taste components of Agaricus blazei, Antrodia camphorata and Cordyceps militaris mycelia”, Food Chem. ,74,pp.2003-2007,2001.
23. 程一華，＜樟芝之成份研究＞，國立臺灣師範大學，碩士論文，民國八十二年。
24. 黃惟敏，＜樟之微量成分的研究(II)＞，私立靜宜大學，碩士論文，民國八十八年。
25. Yang, S.W et al., “Steroids and triterpenoids of Antrodia cinnamomea—a fungus parasitic on Cinnamomum micranthum”,
Phytochem ,41, pp.1389-1392 ,1996.
26. Lee I.H et al.,” Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects”, FEMS Microbi. Lett, 209, pp.63-67,2002.
27. Mizuno, T et al., “Antitumor activity and some properties of water-soluble polysaccharides from Himematsutake, the fruiting body of Agaricus blazei murill”, Agric. Biol. Chem, 54, pp.2889-96, 1990.
28. Song, T. Y. and Yen, G. C., “Protective effects of fermented filtrate from Antrodia camphorata in submerged culture against CCl4-induced hepatic toxicity in rats”, Journal of Agricultural &; Food Chemistry, 51, pp.1571-7, 2003.
29. Eo, S. K et al., “Antiherpetic activities of various protein bound polysaccharide isolated from Ganoderma lucidum”, J Ethnopharma, 72, pp.475-81, 1999.
30. 黃鈴娟，＜樟芝與姬松茸之抗氧化性質及其多醣組成分析＞，中興大學，碩士論文，民國八十九年。31. Huang, W.W et al., “Pine needle extract induced apoptosis and differentiation in human leukemia cells”, J. Chin. Med. Sci. , 3, pp.197-210 , 2002.
32. Zhang, Z et al.,” Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models”, Oncogene, 23, pp. 3841-3850 , 2004.
33. Zhao, C et al.,”An antitumor lectin from the edible mushroom”. Agrocybe aegerita. Biochem. J, 374 ,pp.321-327,2003.
34. 張中姿，＜樟芝菌絲體之甲醇萃取部分對人類肝癌細胞株(HepG2)生長抑制作用的機轉探討＞，國立台灣大學，碩士論文，民國八十九年。35. 宋祖瑩，＜樟芝深層培養液抗氧化及抗腫瘤特性之研究＞，國立
中興大學，博士論文，民國九十二年。
36. Nakamura, N et al., “Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line”, J. Nat. Prod. ,67, pp. 46-48, 2004.
37. 周郁傑，＜樟芝多醣體藉由免疫調節抑制血管新生作用及機制之研究＞，中興大學，碩士論文，民國九十四年。38. Shen, Y.C et al.,”Anti-inflammatory activity of the extracts from mycelia of Antrodia camphorata cultured with water-soluble fraction from five different Cinnamomum species”, FEMS Microl. Lett. ,231, pp.137-143,2004.
39. 劉千瑈，＜樟芝對樹突狀細胞之免疫調控作用與對巨噬細胞之抗發炎反應＞，國立陽明大學，碩士論文，民國九十五年。40. 蔡明憲等，＜大白鼠口服高劑量樟芝菌絲體之急性毒性試驗」，中華保健食品學會第二屆第一次年會壁報論文摘要，民國九十年。
41. 沈立言，＜牛樟芝菌絲體發酵萃取液對肝臟生理機能性之影響＞，89年度保健食品研究開發計劃心得發表會，頁191-198，台灣，民國八十九年。
42. 歐貴仁，＜樟芝的保肝功效與保肝有效成分純化之研究＞，成功 大學，碩士論文，200543. Hseu, Y.J et al., “Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes”, Life Sci. ,71, pp.469-482 ,2002.
44. 陳勁初等，＜姬松茸與樟芝菌絲體之毒性與致突變性之研究＞，中華保健食品學會第二屆第一次年會壁報論文摘要，台灣，民國九十年。
45. 蔡雁暉等，＜樟芝菌絲體液體深層培養液對過氫誘發人類肝細胞 氧化傷害之保護作用＞，中華民國食品科學技術學會第三十一次會員大會論文摘要，台灣，民國九十年。
46. 謝如婷，＜微量元素對牛樟芝發酵物生理活性與抗氧化活性影響之探討＞，南台科技大學，碩士論文，民國九十七年。47. 汪國麟，＜樟芝菌絲體對大鼠肝腎汞傷害之影響＞，弘光科技大學，碩士論文，民國九十六年。48. 嚴貴榮，＜樟芝對STZ 誘發高血糖鼠血糖調節與抗氧化之影響＞，輔仁大學，碩士論文，民國九十一年。49. 葉怡真，＜樟芝對血管內皮細胞之影響及保心血管疾病之機制探 討＞，中國醫藥大學，碩士論文，民國九十一年。50. 李雨薇，＜牛樟芝菌絲體醱酵液對血管新生抑制作用及其機制之探討＞，長庚大學，碩士論文，民國九十六年。51. 鍾幸君，＜樟芝對平滑肌細胞的遷移及老鼠頸動脈新生內膜形成 的抑制作用＞，南台科技大學，碩士論文，民國九十六年。52. 朱建儒，＜探討通氣量對於樟芝醱酵生產生物鹼之影響＞，中央 大學，碩士論文，民國九十一年。53. Juan C. Cedrón et al., The Alkaloids: Chemistry and Biology, Volume 68, 2010.Nakanishi T et al., “Structural Considerations of NK109, an Antitumor Benzo phenanthridine Alkaloid”, Journal of Natural Product, 62, pp.864-867,1999.
54. Nakanishi T et al., “Structural Considerations of NK109, an Antitumor Benzo phenanthridine Alkaloid”, Journal of Natural Product, 62, pp.864-867,1999.
55. Lindsay B. S et al., “Structural Studies of Cytotoxic Marine Alkaloids: Synthesis of Novel Ring-E Analogues of Ascididemin and their in vitro and in vivo Biological Evaluation” , Tetrahedron, 56, pp.497–505, 2000.
56. Tikhomiroff C and Jolicorur M., “Screening of Catharanthus roseus Secondary metabolites” ,Journal of chromatography A, 955, pp.87-93,2002.
57. Pedro Casadoet al., “Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells” , Cancer Letters, 247, pp.273-282, 2007.
58. G.M. Cragg and D.J. Newman ., “Natural Product Sources of Drugs: Plants, Microbes, Marine Organisms, and Animals”, Comprehensive Medicinal Chemistry II, 1, pp.355-403 , 2007.
59. W.B. Turner and D.C. Aldridge, Fungal metabolites , volume II,Academic Press, London, Phytochemistry, Volume 23, Issue 3, 1984, Page 712.
60. I.H. Cherng et al., “Triterpenoides from Antrodia cinnamomea ” Phytochemistry ,41,pp.263-267,1996.
61. S.W. Yang et al., “Steroids and triterpenoids Of Antrodia cinnamomea–A fungus parasitic on Cinnamomum micranthum. ”, Phytochemistry ,41,pp.1389-1392,1996.
62. Shen, Y. C et al., “Evaluation of the anti-inflammatory activity of zhankuic acids isolated from the fruiting bodies of Antrodia camphorate”, Planta Medica, 70, 310-4, 2004.
63. 林豔琪，＜樟芝固態培植體之成分分析及功能性評估＞，南台科技大學，碩士論文，民國九十三年。64. Chambers R. W, “Chemical carcinogensis: A Biochemical Overview”, Clinical Biochemistry,18 ,pp.158-168 ,1985.
65. Josep M. Llovet and Jordi Bruix., “Novel advancements in the management of hepatocellular carcinomanext term in previous term”, Journal of Hepatology , 48, pp.S20-S37, 2008.
66. Luca Persano et al., “Anti-angiogenic gene therapy of cancer: Current status and future prospects”, Molecular Aspects of Medicine ,28,pp.87–114,2007.
67. Paget, S, “The distribution of secondary growths in cancer of the breast”, Cancer Metastasis Rev, 8, p98, 1989.
68. Muller, A et al., “Involvement of chemokine receptors in breast cancer metastasis”, Nature, 410, p50, 2001.
69. Takaoka, A et al., “Anti-cell death activity promotes pulmonary metastasis of melanoma cells”, Oncogene, 14, p2971, 1997.
70. Owen-Schaub, L.B et al., “Fas and Fas ligand interactions suppress melanoma lung metastasis”, J. Exp. Med, 188,p1717, 1998.
71. Megumi Iiizumi et al., “Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy”, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1786, Issue 2, pp. 87-104,2008.
72. Frank Q. Li et al., “Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53”, Virology, Volume 365, Issue 2, pp.435-445 , 2007.
73. W.C.G. van Staveren et al.,” Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?”, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1795, Issue 2, pp. 92-103,2009.
74. Koepp, D. M et al.,” How the cyclin became a cyclin: regulated proteolysis in the cell cycle”, Cell ,97, pp.431-434 ,1999.
75. Silvia Lapenna and Antonio Giordano., “Cell cycle kinases as therapeutic targets for cancer”, Nature Reviews Drug, pp.547-566 ,2009.
76. Arnaud Besson1 et al., “CDK Inhibitors: Cell Cycle Regulators and Beyond. Developmental Cell, Volume 14, Issue 2, pp.159-169, 2008.
77. Hollstein M et al.,” p53 mutations in human cancer.”, Science ,253, pp. 49-53, 1991.
78. Harris CC et al.,”Clinical implications of the p53 tumor suppressor gene.”, N. Engl. J. Med. ,329,pp.1318-1327, 1993.
79. Attardi, L. D. “The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability:lessons from mouse models.” Mutat. Res.569, pp.145–157,2005.
80. Tanel Punga et al.,” Adenovirus 2 E1B-55K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters”, FEBS Letters, Volume 552(2-3), pp.214-218,2003.
81. Wagner P, Appel K, Issinger OG and Montenarh M. On the interaction of p53 with casein kinaseⅡ. Int. J. Oncol. 4: 491-498, 1994.
82. Zha J et al.,”Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis”. Science ,290,pp.1761-1765, 2000.
83. Miyashita T et al., ”Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell,80,pp293-299, 1995.
84. Hala Gali-Muhtasib. “Cyclin-dependent kinase inhibitors from natural sources: recent advances and future prospects for cancer treatment” , Advances in Phytomedicine, Volume 2, pp.155-167, 2006.
85. Maria Rescigno et al., “Challenges and prospects of immunotherapy as cancer treatment”, Biochimica et Biophysica Acta(BBA) - Reviews on Cancer, Volume 1776, Issue 1,pp.108-123, 2007.
86. Goodlett, C et al., “Mechanisms of alcohol-induced damage to the developing nervous system”, Alcohol Research &; Health : the journal of the National Institute on Alcohol Abuse and Alcoholism ,25,pp.175-84 ,2001.
87. Bríd M. Ryanet al.,” Survivin: A new target for anti-cancer therapy”, Cancer Treatment Reviews , Volume 35 , 553–562, 2009.
88. Fadeel, B and Orrenius, S., “Apoptosis: a basic biological phenomenon withwide-ranging implications in human disease”, J Intern Med ,258, pp.479-517 ,2005.
89. Schafer, Z and Kornbluth, S.,”The apoptosome: physiological,developmental,and pathological modes of regulation”, Developmental cell ,10, pp.549-61 ,2006.
90. Chipuk, J.E et al., “Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis”, Science ,303, pp.1010–14 ,2004.
91. Lemarie, A et al., “Cadmium induces caspase-independent apoptosis in liver Hep3B cells: role for calcium in signaling oxidative stress-related impairment of mitochondria and relocation of endonuclease G and apoptosis-inducing factor”, Free Radic. Biol. Med, 36, pp.1517-1531,2004.
92. Fleury, C et al., “Mitochondrial reactive oxygen species in cell death signaling”, Biochimie ,84, pp.131-141 ,2002.
93. Devalingam Mahalingam et al., “TRAIL receptor signalling and modulation: Are we on the right TRAIL?”, Cancer Treatment Reviews, Volume 35, Issue 3, pp.280-288, 2009.
94. Teni Boulikas. “Molecular mechanisms of cisplatin and its liposomally encapsulated form, Lipoplatin™. Lipoplatin™ as a chemotherapy and antiangiogenesis drug”, Cancer Therapy , 5, pp.351-376, 2007.
95. Frank A.E. Kruyt. ”TRAIL and cancer therapy”. Cancer Letters, Volume 263, Issue 1, pp.14-25, 2008.
96. Galle, P. R. “Apoptosis in liver disease”, Journal of Hepatology, 27,pp.405-412,1997.
97. Bharat B. Aggarwal et al.,” Models for prevention and treatment of cancer: Problems vs promises”, Biochemical Pharmacology, 78, 1083–1094,2009.
98. Elza C. de Bruin et al.,” Apoptosis and non-apoptotic deaths in cancer development and treatment response”, Cancer Treatment Reviews , 34, 737– 749, 2008.
99. Swamy, S. M. K. and Tan, B. K. H., “Cytotoxic and immunopo- tentiating effects of ethanolic extract of Nigella sativa L. seeds”, Journal of Ethnopharmacology ,70 ,pp.1-7, 2000.
100. Sarzynkiewicz, Z et al., “Features of apoptotic cells measured by flow cytomery”, Cytometry ,13, pp.795-808 ,1992.
101. http://www.biomol.de/
102. Koeplinger KA et al., “Caspase 8: an efficient method for large-scale autoactivation of recombinant procaspase 8 by matrix adsorption and characterization of the active enzyme”, Protein Expression and purification, 18, pp.378-387,2000.
103. Wang, T.-H. and Wang, H.-S., “Apoptosis: (2) characteristics of apoptosis, “Journal of the Formosan Medical Association ,98,
pp.531-542,1999.
104. Galle, P. R. “Apoptosis in liver disease”, Journal of Hepatology ,27, pp.405-412,1997.
105. Hanif, R et al., “Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway”, Biochem Pharmacol, 52, pp.237-45,1996.
106. Zhang, G et al ., “Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells”, Leuk. Res ,24, pp.385-392 ,2000.
107. Donald W. Nicholson and Nancy A. Thornberry,” APOPTOSIS:Life and Death Decisions”, Science ,299,pp.214-215,2003.
108. Simone Fuldaa et al., ” Apoptosis signaling in cancer stem cells”,
The International Journal of Biochemistry &; Cell Biology ,42 ,pp.31–38,2009.
109. Tuzz-Ying Song et al.,” Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture”, Journal of Ethnopharmacology ,100,pp.158-167,2005.
110. 黃億富，＜TTK/hMps1在異常細胞分裂中調控p53蛋白之機制探討＞，國立清華大學，博士論文，民國九十八年。111. Rieko Nango et al.,” Jun N-terminal kinase activation and upregulation of p53 and p21WAF1/CIP1 in selenite-induced apoptosis of regenerating liver”, European Journal of Pharmacology, 471(13), pp.1-8 ,2003.
112. Ya-Ling Hsu et al., “Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines”, Cancer Letters, Volume 221, Issue 1, pp.77-89, 2005.
113. Kuo et al., “Apoptotic effects of previous termAntrodianext term cinnamomea fruiting bodies extract are mediated through calcium and calpain-dependent pathways in Hep 3B cells”, Food and Chemical Toxicology ,44, pp. 1316–1326,2006.
114. Ze Tian, Ruile Pan et al., “Cimicifuga foetida extractnext term inhibits proliferation of hepatocellular cells via induction of cell cycle arrest and previous termapoptosis”, Journal of Ethnopharmacology, Volume 114, Issue 2, pp. 227-233, 2007.
115. Tuzz-Ying Song et al., “Induction of apoptosis in human hepatoma cells by mycelia of Antrodia camphorata in submerged culture”, Journal of Ethnopharmacology ,100, pp.158–167 ,2005.
116. Hui Liu et al., “Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway”, Cancer Letters, Volume 270, Issue 2, pp.242-249, 2008.
117. Marx J.,“How cell cycle toward cancer”,Science., 263, pp.319-321,1994.
118. Bontenbal M et al., “Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)” ,Eur J Cancer Clinoncol, ; 24, pp.1409-14,1988.
119. Maryanne Donovan et al.,” Control of mitochondrial integrity by
Bcl-2 family members and caspase-independent cell death”, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1644(2-3), pp.133-147,2004.
120. Martin R. Sprick et al., “The interplay between the Bcl-2 family and
death receptor-mediated apoptosis”, Biochimica et Biophysica Acta
(BBA) - Molecular Cell Research, 1644(2-3),pp. 125-132,2004.
121. Zhang L, et al.,”Role of Bax in the apoptotic response to anticance
Agents”,Science ,90,pp.989-992,2002.
122. Kuo, P.L et al.,”Rhein inhibits the growth and induces the apoptosis of Hep G2 cells”, Planta Med,70, pp.12-16,2004.
123. Tuzz-Ying Song et al.,” Induction of apoptosis in human hepatoma
cells by mycelia of Antrodia camphorata in submerged culture”, Journal of Ethnopharmacology, 100(1-2), pp.158-167, 2005.
124. Emma S et al.,”The role of p53 and pRB in apoptosis and cancer”,
Current Opinion in Genetics &; Development, 12(1),pp. 60-66,2002